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Abstract: F1000 recommendations have been assessed as a potential data source for research 
evaluation, but the reasons for differences between F1000 Article Factor (FFa scores) and citations 
remain unexplored. By linking recommendations for 28,254 publications in F1000 with citations 
in Scopus, we investigated the effect of research level (basic, clinical, mixed) and article type on 
the internal consistency of assessments based on citations and FFa scores. Research level has little 
impact on the differences between the two evaluation tools, while article type has a big effect. 
These two measures differ significantly for two groups: 1) non-primary research or 
evidence-based research are more highly cited but not highly recommended, while 2) 
translational research or transformative research are more highly recommended but gather fewer 
citations. This can be expected since citation activity is usually practiced by academic authors 
while the potential for scientific revolutions and the suitability for clinical practice of an article 
should be investigated from a practitioners’ perspective. We conclude with a recommendation that 
the application of bibliometric approaches in research evaluation should consider the proportion of 
three types of publications: evidence-based research, transformative research, and translational 
research. The latter two types are more suitable for assessment through peer review. 
 
 
Introduction  
 
Many stakeholders are concerned with how to properly assess the true impact of biomedical 
research. Investigators and research institutions often assess impact through such simple measures 
as publications in peer-reviewed journals, the impact factors of those journals, success in acquiring 
research grants, and the awarding of patents for novel inventions (Dembe, Lynch, Gugiu, & 
Jackson, 2014). The San Francisco Declaration on Research Assessment (DORA), initiated by the 
American Society for Cell Biology (ASCB) together with a group of editors and publishers of 
scholarly journals, recognizes the need to improve the methods applied to evaluate the outputs of 
scientific research. The general recommendation is “Do not use journal-based metrics, such as 
Journal Impact Factors, as a surrogate measure of the quality of individual research articles, to 
assess an individual scientist’s contributions, or in hiring, promotion, or funding decisions” (Way 
& Ahmad, 2013). 
Citation analysis, as one of the key methodologies in bibliometrics, has become an important 
tool for research performance assessment in the biomedical sciences (Du & Tang, 2013; Patel et 
al., 2011; Walker, Sykes, Hemmelgarn, & Quan, 2010). However, before bibliometric evaluation 
became widely accepted, peer review was the main tool used for research evaluation. This 
traditional approach received a new breath of life when the Faculty of 1000 Biology (F1000 
Biology) was launched in 2002 to evaluate the quality of biomedical literature through a 
post-publication peer review system. F1000 Medicine was initiated in 2006, and the two services 
were combined in 2009 to form F1000Prime, which has built a peer-nominated global team of 
faculty members tasked to identify and recommend important biomedical articles (Vardell & 
Swogger, 2014; Wets, Weedon, & Velterop, 2003). When faculty members recommend an article, 
they also write a brief review explaining its importance and rate it as “Good”, “Very Good” or 
“Exceptional” (equivalent to scores of 1, 2 or 3 stars, respectively). F1000Prime uses these 
individual scores to calculate a total score for each article, namely F1000 Article Factor (FFa 
score). F1000 recommendations have been assessed as a potential new data source for research 
evaluation (Waltman & Costas, 2014).  
The association between citations and FFa scores has been investigated in recent years. Allen, 
Jones, Dolby, Lynn, and Walport (2009) compared 687 research papers assessed by Wellcome 
Trust reviewers with citations and F1000 ratings, and found that despite a strong positive 
association at an aggregate level, bibliometric measures may not be sufficient for evaluating  
research quality and importance, and especially when assessing individual papers or small groups 
of research publications. Wardle (2010) argued that within the 1,530 publications in the field of 
ecology, recommendations are a poor predictor of highly cited publications, which may be caused 
by the uneven distribution of F1000 faculty members over different areas of ecological research. 
Using a sample of 1,397 articles on genomics and genetics, Li and Thelwall (2012) reported a 
weak correlation between recommendations and citations, which measure different dimensions 
from different perspectives (recommendations measure the article quality from an expert 
perspective whereas citations measure research impact from an author perspective). Based on the 
data from 125 papers on cell biology or immunology from F1000 and InCites, Bornmann and 
Leydesdorff (2013) investigated the relationship between peer ratings and bibliometric metrics. 
They concluded that the correlation between recommendations and the best citation-based metrics 
has “at least a medium effect size.” Mohammadi and Thelwall (2013) found a low but significant 
correlation between FFa scores and citations for a random sample of 900 clinical articles 
recommended by F1000. However, all the above studies were based either on relatively small 
samples or on just one or two specific subject categories. Waltman and Costas (2014) analyzed 
F1000 recommendations more comprehensively, taking into account all recommendations in the 
F1000 system. They found a clear correlation between F1000 recommendations and citations. 
However, the correlation was relatively weak, at least weaker than that between journal impact 
and citations. Mohammadi and Thelwall (2013) distinguished different types of publications (as 
indicated by labels such as “new finding”, “confirmation”, and “changes clinical practice” 
assigned by F1000 faculty members) and found a significant difference in citations and FFa scores 
for the two article labels: “new finding” and “changes clinical practice”. They suggested that 
differences between recommendations and citations may relate to the type of research reported in 
a publication. But the interpretations of the differences require a more in-depth investigation, 
including analysis of the reasons F1000 faculty members give to recommend a publication, and 
possible biases in F1000’s peer-nomination system for selecting faculty members. Waltman and 
Costas (2014) also suggested that more research is needed to identify the main reasons for 
differences between recommendations and citations in assessing the impact of publications. 
Inspired by Mohammadi and Thelwall (2013) and Waltman and Costas (2014), we sought to 
investigate the differences between recommendations and citations from the perspectives of 
biomedical research level and article type (as indicated by articles labels). The concept of 
“research level”, i.e., whether the research tends to be basic or applied/clinical, was first 
introduced by Narin, Pinski, and Gee (1976), who assigned 900 biomedical journals to one of four 
research levels, namely “Clinical Observation” (Level 1), “Clinical Mix” (Level 2), “Clinical 
Investigation” (Level 3), or “Basic Research” (Level 4), ranging from the most applied to the most 
fundamental. Articles assigned to “Clinical Mix” indicated such studies that contain a fairly even 
mix of observation and investigation, representing an intermediate level between medical research 
and clinical observation. This method has two limitations. First, it assumes all papers in a journal 
share a common research level. Second, the journal research level is assumed to remain constant, 
even if in reality it changes over time. To address these deficiencies, Lewison and Paraje (2004) 
created their own method for classifying the research level of biomedical research journals as 
clinical, basic, or somewhere in between. Their classification is based on counting articles that 
contain one of about 100 “clinical” title words, or one of a similar number of “basic” title words, 
or both. This allows journals to be classified rapidly and transparently, and also allows for changes 
in their research level over time, as well as for classification of individual papers in mixed journals 
as clinical or basic. Translational research, which is aimed at reducing the time required for basic 
discoveries to be translated into effective patient treatment, has become a topic of great interest in 
the biomedical community over the past several years. Much of the focus is on the linkages 
between basic biomedical research and clinical medicine. Subsequently, research level has been 
used to characterize translational pathways in biomedical research (Cambrosio, Keating, Mercier, 
Lewison, & Mogoutov, 2006; Jones, Cambrosio, & Mogoutov, 2011) and to assess the 
translational capacity of medical researchers and teams based on the research level of a 
researcher’s output (Boyack, Klavans, Patek, Yoon, & Ungar, 2013). F1000 uses its own field 
classification system, which differs from the journal-based subject categories used by Web of 
Science or Scopus. In this study, we classify research articles into three levels: basic, clinical and 
mixed, according to the specialty of F1000 recommender. If an article is recommended only by 
faculty members specialized in biology-related subjects (scientists), it is classified as “Basic 
Research”. If an article is recommended only by faculty members in medicine-related subjects 
(clinicians), it is classified as “Clinical Research”. Finally, if an article is recommended by faculty 
members specialized in an area that involves both biological and medical research topics, or if it is 
rated by both scientists and clinicians, then it is classified as “Mixed Research”; this last 
classification thus denotes articles of interest to both basic and clinical researchers. Previous 
classifications of biomedical research levels were based either on predetermined sets of biological 
versus clinical journals (Lewison & Paraje, 2004; Opthof, 2011; Seglen, 1997), or on 
keywords/MeSH terms related to basic research or clinical research (van Eck, Waltman, van Raan, 
Klautz, & Peul, 2013; Fajardo-Ortiz, Duran, Moreno, Ochoa, & Castano, 2014a, 2014b). This 
study instead assigns publications to basic, clinical or mixed research according to the research 
fields of faculty members who recommend them. The concept of research level as operationalized 
in this study is validated in the following section.   
Faculty members also tag articles with one or more of the following labels: 1) Changes Clinical 
Practice: the article recommends a complete, specific and immediate change in practice by 
clinicians for a defined group of patients; 2) Confirmation: the article validates previously 
published data or hypotheses; 3) Controversial: the article challenges established dogma; 4) Good 
for Teaching: a key article in the field and/or one which is well written; 5) Interesting Hypothesis: 
the article presents a new model; 6) New Finding: the article presents original data, models or 
hypotheses; 7) Novel Drug Target: the article suggests new targets for drug discovery; 8) 
Refutation: the article disproves previously published data or hypotheses; and 9) Technical 
Advance: the article introduces a new practical/theoretical technique, or a novel use of an existing 
technique. F1000 further assigns other document types: Clinical Trial, Systematic 
Review/Meta-analysis and Review/Commentary. We primarily seek to answer two fundamental 
research questions: 
(1) Does research level (basic, clinical or mixed) impact the association between citations and 
FFa scores? 
(2) Do different article types impact the association between citations and FFa scores? 
 
Materials and methods 
The subject category in F1000 is a three level system that includes subjects, sections and topics. 
The reviewer team comprises an international advisory board, faculty heads, section heads, and 
faculty members, together with their associate faculty members. The international advisory board 
assists with the selection of the faculty heads for each subject. Faculty heads divide their subjects 
into major sections and help nominate section heads. Section heads are acknowledged experts in 
their fields and are responsible for dividing their sections into topics and for selecting suitable 
faculty members to review the literature on each topic area. The number of faculty members is 
broadly linked to the total number of articles published in the various topic areas. 
Sample Selection  
Articles recommended by faculty members are assigned to his/her discipline, organized into 
24 biology-related and 20 medicine-related subjects. As is shown in Table 1, each 
medicine-related subject has its own separate faculty heads, section heads or faculty members, yet 
this independent reviewer system does not exist in nearly half of all biology-related subjects 
(11/24). The number of recommended articles was unevenly distributed across biology-related 
subjects relative to medicine-related subjects. First, more than two-thirds of articles 
(80,094/115,565, 67.7%) are recommended by faculty members specialized in biology-related 
subjects. This proportion is much larger than that for medicine-related subjects (45,515/115,565, 
38.1%). Second, within biology-related subjects, the top three subject categories in which articles 
were frequently recommended were cell biology, molecular medicine, and genomics and genetics, 
accounting for 41.8%, 31.2% and 27.4%, respectively, higher than the percentages for cancer 
biology, plant biology, cardiovascular biology, gastrointestinal biology, and so on. In comparison, 
articles are relatively balanced in their coverage of most medicine-related subjects, with each 
subject typically accounting for around 3‒6% of all articles.  
The sum of the papers under all subjects (468,928) was almost four times the total number of 
biology and medicine articles (115,565). A single article thus may belong to multiple subjects if it 
is recommended by faculty members from different subjects, so the papers assigned to a subject 
do not necessarily only reflect the activities of faculty members specialized in that category. 
Among the 44 total subjects, several pairs represent biological and medical research on the same 
disease area, such as Cancer Biology and Oncology, Cardiovascular Biology and Cardiovascular 
Disorders, Neuroscience and Neurological Disorders, Respiratory Biology and Respiratory 
Disorders, or Renal Biology and Nephrology. Given the complicated recommendation activities of 
reviewers and the uneven distribution of articles across different subjects, as well as the objectives 
of this study being to investigate research level in the continuum from basic to clinical research, 
three biology-medicine subject pairs with a relative large number of articles were selected for 
study: Cancer Biology, Oncology, Cardiovascular Biology, Cardiovascular Disorders, 
Neuroscience and Neurological Disorders. 
Table 1. Distribution of reviewers and articles (published from 1999 to 2013) across biology- and medicine-related subjects 
F1000 Biology reviewers articles F1000 Medicine reviewers articles 
N % N % 
Cell Biology  1437 49448 42.8 Neurological Disorders  863 7442 6.4  
Molecular Medicine  N/A 36022 31.2 Oncology  411 6731 5.8  
Genomics & Genetics  574 31640 27.4 Public Health & 
Epidemiology  
282 6300 5.5  
Biotechnology  N/A 27395 23.7 Infectious Diseases  529 6107 5.3  
Physiology  612 24204 20.9 Anesthesiology & Pain 
Management  
886 5851 5.1  
Biochemistry  3 23438 20.3 Gastroenterology & 
Hepatology  
632 5009 4.3  
Pharmacology & Drug 
Discovery  
809 21792 18.9 Cardiovascular Disorders  432 4832 4.2  
Structural Biology  708 19918 17.2 Diabetes & Endocrinology  385 4643 4.0  
Microbiology  866 16853 14.6 Critical Care & Emergency 
Medicine  
328 4495 3.9  
Developmental Biology  624 16622 14.4 Respiratory Disorders  492 4462 3.9  
Neuroscience  1195 16542 14.3 Psychiatry  512 4236 3.7  
Chemical Biology  497 16340 14.1 Rheumatology & Clinical 
Immunology  
581 3955 3.4  
Bioinformatics & 
Computational Biology  
N/A 15331 13.3 Women's Health  291 3944 3.4  
Immunology  986 13157 11.4 Hematology  530 3303 2.9  
Molecular Biology  N/A 12907 11.2 Dermatology  495 3181 2.8  
Evolutionary Biology  N/A 10500 9.1 Urology  325 3018 2.6  
Cancer Biology  N/A 9169 7.9 Nephrology  315 2432 2.1  
Plant Biology  447 6832 5.9 Otolaryngology  266 1868 1.6  
Ecology  620 6583 5.7 Ophthalmology  332 890 0.8  
Metabolic & Endocrine 
Science  
N/A 3006 2.6 Research Methodology  96 796 0.7  
Cardiovascular Biology  N/A 3001 2.6     
Gastrointestinal Biology  N/A 2080 1.8     
Renal Biology  N/A 1344 1.2     
Respiratory Biology  N/A 1309 1.1     
N/A: This subject was created by grouping relevant sections from other subjects, and thus, does not have separate 
Faculty Heads, Section Heads or Faculty Members. 
 
Data Collection 
In this study, F1000’s advanced search was used to select articles published between 1999 and 
2013 and recommended by faculty members in the three subject pairs mentioned above. We 
captured the bibliographic and F1000 information for each article, including author(s), title, 
journal, publication date, FFa score, and article labels. Thomson Reuters Journal Citation Report 
(JCR) for 2013 was used to collect journal impact factors. Scopus was used to search citations for 
each article because of the following: 1) Previous studies have found that oncology or general 
medicine articles published from 1996 onward received more citations from Scopus than from the 
Web of Science (Lewison & Paraje, 2004; Seglen, 1997), and Scopus covered clinical research 
journals better than Web of Science does (Opthof, 2011). 2) F1000 states that only about 15% of 
its articles come from high-profile popular journals such as Science and the New England Journal 
of Medicine, with the remaining 85% coming from a wider range of more specialized and less 
popular journals (Vardell & Swogger, 2014). We thus use Scopus for citation matching to capture 
the wider citation impact. 
Dataset 1  To evaluate the general distribution of articles across different subjects and journals, 
the analysis included all articles published between 1999 and 2013, and recommended by F1000 
faculty members specialized in the abovementioned six subjects, a total of 47,446 articles. 
Dataset 2  A link between listings in the F1000 dataset and the Scopus database was established 
if the publications shared either the same digital object identifier (DOI) or the same journal title, 
volume number, issue number, and first author name (i.e., last name and initials). Some scholars 
have claimed that reliably determining the citation impact of papers requires a sufficiently wide 
citation window of at least 3 years (Cambrosio et al., 2006), and generally more than 80% of 
first-citations are accrued within an initial 3-year window and more than 90% within an initial 
5-year citation window (Glänzel, Schlemmer, & Thijs, 2003). Thus, a 3-5 year citation window for 
the most recently published articles was adopted. We only selected the 31461 articles published 
between 1999 and 2010 for citation matching. The citation data was retrieved on August 2014. 
F1000 conference posters (n=44) and the retracted articles (n=43) were excluded, leaving 31374 
articles. To establish a link between individual papers and bibliometric data, two procedures were 
used. 1) A total of 29,361 papers in the dataset could be matched with a paper in the Scopus 
database using DOI. 2) For 1279 of the 2013 remaining papers, no match was achieved with DOI, 
but a match could be achieved for the title, journal, volume and issue. Citations in Scopus were 
then drawn for 30640 of the total 31374 papers (97.6%). This percentage exceeds 91% obtained 
by Bornmann (2014) and the 93% quoted by Waltman and Costas (2014), who used a similar 
procedure to match data from F1000 with bibliometric data in Web of Science. Because one article 
may be classified under multiple subjects, it may be recommended by faculty members specialized 
in different subjects. Therefore we further examined the primary data collection procedure and 
deleted 2386 duplicated articles recommended by faculty members affiliated with two or more of 
the six subjects, leaving 28,254 articles in the sample. Dataset 2 is a subset of dataset 1. 
 
Results 
The analytical results are presented in three subsections. We first provide general statistics on: 1) 
the distribution of articles across subjects and journals; 2) the association between FFa scores and 
the other three citation measures; and 3) the content of articles across research levels as reflected 
by article labels, journals in which they were published and terms associated with them. We then 
investigate the effect of research level and article type on the internal consistency of assessments 
based on citations and FFa scores.  
General Statistics 
Distribution of articles across subjects and journals  Figure 1 shows the annual number of 
recommended papers in these three subject pairs. Because F1000 Biology was launched in 2002 
and F1000 Medicine in 2006, the annual number of recommended papers on biology-related 
subjects rises early and then remains relatively stable, while that for medicine-related subjects 
displays a significant increase. 
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Figure 1. Annual number of recommended papers, 1999-2013. 
 
Of the 1,904 journals in Dataset 1, 311 were not indexed by Web of Science. In Table 2, nearly 
30% of cancer biology-related articles came from very high profile journals such as Nature, PNAS, 
Cell and Science, while the largest sources for the other five subjects were more specialized 
journals (e.g., Journal of Clinical Oncology and Blood for Oncology, Circulation Research and 
Circulation for Cardiovascular Biology and Cardiovascular Disorders, and Journal of 
Neuroscience and Neurology for Neuroscience and Neurological Disorders). 
Table 2. Top 10 journals in each discipline by number of articles 
Journal No. % Journal No. % 
Cancer Biology   Oncology   
Nature 772 8.4 J Clin Oncol 652 9.8  
Proc Natl Acad Sci U S A 642 7.0 Blood 307 4.6  
Cell 630 6.9 N Engl J Med 233 3.5  
Science 529 5.8 Nature 142 2.1  
J Cell Biol 429 4.7 Cancer Res 142 2.1  
Mol Cell 370 4.0 Lancet Oncol 134 2.0  
Nat Cell Biol 342 3.7 J Urol 122 1.8  
J Biol Chem 321 3.5 Ann Oncol 119 1.8  
Genes Dev 308 3.4 Proc Natl Acad Sci U S A 115 1.7  
Cancer Cell 306 3.3 Cancer 108 1.6  
Cardiovascular Biology   Cardiovascular Disorders   
Circ Res 187 6.2 Circulation 502 10.5  
Proc Natl Acad Sci U S A 178 5.9 J Am Coll Cardiol 381 8.0  
Circulation 149 5.0 N Engl J Med 304 6.4  
Hypertension 132 4.4 JAMA 136 2.8  
Nature 131 4.4 Lancet 128 2.7  
J Clin Invest 109 3.6 Eur Heart J 112 2.3  
Blood 89 3.0 Am J Cardiol 105 2.2  
J Biol Chem 79 2.6 J Vasc Surg 98 2.0  
Am J Physiol Heart Circ Physiol 70 2.3 Hypertension 90 1.9  
Nat Med 69 2.3 J Am Soc Nephrol 81 1.7  
Neuroscience   Neurological Disorders   
J Neurosci 1894 11.5 Neurology 462 6.3  
Neuron 1341 8.1 J Neurosci 258 3.5  
Proc Natl Acad Sci U S A 1184 7.2 Brain 248 3.4  
Nature 1116 6.8 Stroke 210 2.8  
Nat Neurosci 1031 6.3 Proc Natl Acad Sci U S A 188 2.5  
Science 917 5.6 Nature 159 2.2  
Cell 544 3.3 Ann Neurol 158 2.1  
Development 387 2.3 N Engl J Med 157 2.1  
J Biol Chem 314 1.9 Pain 149 2.0  
Curr Biol 298 1.8 Science 133 1.8  
 
Association between FFa scores and the other three citation measures  Within dataset 2, we first 
analyzed the distribution of FFa scores and citations for 28,254 articles, and found that the 
statistical curves for both FFa scores and citations follow a long-tailed distribution. In other words, 
there are many papers with few citations and low FFa scores. The majority of the studied articles 
had FFa scores of only 1 or 2, with these two categories comprising 51% (n=14,421) and 28% 
(n=7,852) of the total, respectively. Since the citations and FFa scores of these 28,254 articles do 
not follow a normal distribution, skewed distributions should not be studied in terms of central 
tendency statistics such as arithmetic means, but rather using nonparametric statistics, such as the 
top 1%, top 10%, etc. Hence we examined the distribution pattern of citations and FFa scores in 
terms of five percentiles, namely top 0.1%, top 1%, top 10%, top 20%, and top 50%. Table 3 
displays data on the minimum number of citations and FFa scores needed to meet these five 
percentile breakdowns in the dataset. 
Table 3. Minimum number of citations and FFa scores needed for inclusion in five percentile categories. 
Percentiles N FFa Scores N Citations 
Top 0.1% 29 20 29 2597 
Top 1% 256 11 283 962 
Top 10% 2156 5 2822 265 
Top 20% 5941 3 5663 160 
Top 50% 13833 2 14196 62 
 
The Journal Impact Factor is the average number of citations accrued in the JCR year by articles 
from the given journal published in the past two years. The Immediacy Index is the average 
number of times an article is cited in the year it is published, indicating how quickly articles in a 
journal are cited. In general, there is only a medium level of association between FFa scores and 
the other three citation measures, namely Journal Impact Factor (Spearman r = 0.428, p < 0.01), 
Journal Immediacy Index (Spearman r = 0.410, p < 0.01) and total citations (Spearman r = 0.363, 
p < 0.01). In the next section, we will investigate the causes of the differences between FFa scores 
and citations. 
 
Content of articles across research levels  In our sample, the numbers of papers classified as 
basic, clinical or mixed research from the three biology-medicine subject pairs are 18,493, 9,069 
and 692, respectively. We validate the concept of research level as operationalized from the 
perspective of recommender’ research areas and subjective concerns, by examining the objective 
and natural content features of articles across research levels through article labels, journals in 
which they appeared, and terms. 
a) Article labels. Since each paper will be given at least one label, the distribution of article 
labels across research levels was first examined (Figure 2). More than half of the articles assigned 
to “Novel Drug Target”, “Technical Advance”, “New Finding”, “Interesting Hypothesis” and 
“Controversial” were basic, and 80% or more of the articles labeled “Changes Clinical Practice” 
(96%), “Randomized Controlled Trial (RCT) Clinical Trial” (85%), “Systematic 
Review/Meta-analysis” (84%) and “Non-RCT Clinical Trial” (84%) were clinical, clearly 
separating the basic with clinical research articles. In addition, all “General Interest”, 15% of 
“Good for Teaching,” and 11% of “Novel Drug Target” publications were mixed research articles. 
These articles, to some extent, attracted attention from both scientists and clinicians and may 
provide insights into the translation of research to practice. 
 
Figure 2. Distribution of article labels across research levels 
 
b) Journals. The distribution of journals across research levels was then analyzed. As is shown 
in Table 4, more than half of basic research articles were published in either basic science journals 
(e.g., Journal of Neuroscience, Neuron, Cell, Journal of Cell Biology) or multidisciplinary 
journals (e.g., PNAS, Nature or Science). The top ten journals publishing the most clinical articles 
were all clinical-research specific, including Journal of Clinical Oncology, New England Journal 
of Medicine, Circulation, Neurology, Journal of the American College of Cardiology and Blood. 
More than two-thirds of basic-clinical mixed research articles were published in multidisciplinary 
journals (Nature, Science and PNAS), high-profile clinical or basic science journals (New England 
Journal of Medicine and Cell), or relevant translational research journals (Nature Medicine, 
Nature Neuroscience, Nature Genetics, Cancer Cell and Journal of Clinical Investigation). We 
investigated the distribution of terms extracted from 692 mixed research articles in detail. 
 
Table 4. Distribution of journals across research levels 
Basic Research  Clinical Research Mixed Research 
Journal % of 18493  Journal % of 9069 Journal % of 692 
J Neurosci 7.6  J Clin Oncol 4.0 Nature 14.0
PNAS 7.4  N Engl J Med 3.7 Science 12.1
Nature 6.9  Circulation 3.3 N Engl J Med 5.9
Neuron 5.6  Neurology 3.2 Nat Med 5.5
Science 5.5  J Am Coll Cardiol 2.3 PNAS 5.3
Cell 4.4  Blood 2.2 Nat Neurosci 5.2
Nat Neurosci 4.1  PNAS 1.9 Cell 4.8
J Cell Biol 2.8  Brain 1.8 J Neurosci 3.6
J Biol Chem 2.8  Lancet 1.8 Nat Genet 3.5
Curr Biol 2.3  JAMA 1.7 Cancer Cell 2.6
Development 2.0  Neuron 2.6
 J Clin Invest 2.0
 Circulation 1.6
 Lancet 1.4
Accumulated 
percentage 50 
 
 25  70
 
c) Terms  To analyze the content of 692 articles we extracted terms (defined as a sequence of 
nouns and adjectives ending with a noun) from their titles and abstracts using VOSviewer 
(http://www.vosviewer.com/). Two terms are said to co-occur in a publication if they both occur at 
least once in the title or abstract. The larger the number of publications in which two terms 
co-occur, the stronger the relationship between those terms. We chose the top 203 noun phrases by 
selecting the most relevant and important terms that co-occurred in at least eight articles to 
construct and visualize co-occurrence networks (Figure 3), in which terms are located such that 
the distance between two terms indicates their number of co-occurrences, and colors can be used 
to indicate the clusters of terms. Figure 3 indicates a clear distinction between basic and clinical 
research, with basic research located in the left part of the map (the blue and red terms, involving 
cells, molecules and animal related research areas) and clinical research in the right part (the green 
terms, related to human related research areas). Connections between basic research areas on the 
one hand and clinical research areas on the other hand are clearly visible in the term maps. Strong 
linkage exsits between basic and clinical terms, with particularly good examples being “cell” and 
“patient”, “mouse” and “patient”, indicating that clinicians can conduct basic research and 
biologists applied research and both can be interested in each other’s research. The classification 
of such articles as mixed research is thus justified.   
 
Figure 3. Co-occurrence map between “basic” terms (the blue and red terms) and “clinical” terms (the green terms) 
 
Based on the above analysis of article labels, journals and terms, the classification into basic, 
clinical or mixed research from the perspective of recommenders’ research areas and subjective 
concerns is reasonable, and is consistent with the objective and natural content patterns of articles. 
 
Association between citations and FFa scores for different research levels 
There was a similar low but significant correlation between FFa scores and citations for Basic 
Research (Spearman r = 0.356, n = 18493, p < 0.01), Clinical Research (Spearman r = 0.287, n = 
9069, p< 0.01) and Mixed Research (Spearman r = 0.402, n = 692, p < 0.01).  
Since both research level and the percentile interval of citations/FFa scores are categorical 
variables, the column proportions tests (z-test) rather than column means tests (t-test) were used to 
determine the distribution of publications assigned to each research level across six percentile 
intervals of citations/FFa scores (i.e. the “column proportions”). Then these proportions are 
compared among different research levels (based on the relative ranking) (see IBM Knowledge 
Center, SPSS Statistics 20.0.0, http://www-01.ibm.com/support/knowledgecenter/ 
SSLVMB_20.0.0/com .ibm.spss.statistics.help/sig_tests_colprop_ex.htm?lang=en). As is shown in 
Table 5, a subscript letter is assigned to the categories of the column variable, i.e., “A” for basic 
research, “B” for clinical research, and “C” for mixed research. For each pair of columns, the 
column proportions (for each row) were compared using a z-test. If a pair of values was 
significantly different, the values were assigned different subscript letters. For each significant pair, 
the Key Letter of the smaller category was placed under that of the larger category. For example, 
for the set of tests associated with the top 1%-0.1% of FFa scores, B is under A, and both A and B 
are under C, indicating that, for this FFa score class, the proportion of publications assigned to 
mixed research (6.4%) was greater than that assigned to basic research (0.9%), which in turn was 
greater than that assigned to clinical research (0.3%). Within the same class of citations, both the 
letter A and B are under C, but A and B are not reported as a significant pair, i.e., one is not placed 
under the other, implying that for papers with citations ranked in the top 1%-0.1% in our sample, 
mixed research (5.2%) represented a larger proportion than either basic research or clinical 
research, but basic research and clinical research did not differ significantly (each having a 
proportion of 0.8%). 
Table 5. Column proportions test (three research levels vs. FFa Scores/Citations) 
Basic Research (A) Clinical Research (B) Mixed Research (C) 
FFa Scores above top 0.1% 0.001  0.000  0.009 (A B) 
top 1%-0.1% 0.009 (B)  0.003  0.064 (A B)  
top 10%-1% 0.076 (B) 0.027  0.357 (A B)   
top 20%-10% 0.148 (B)  0.090  0.344 (A B)  
top 50%-20% 0.281 (C)   0.286 (C)   0.150  
below top 50% 0.486 (C)  0.594 (A C)  0.077  
total 1 1 1 
Citations above top 0.1% 0.001  0.001  0.004 (A)  
top 1%-0.1% 0.008  0.008  0.052 (A B)  
top 10%-1% 0.096 (B)  0.065  0.250 (A B)  
top 20%-10% 0.112 (B)   0.071  0.182 (A B)  
top 50%-20% 0.327 (B)  0.250  0.311 (B)  
below top 50% 0.456 (C)  0.604 (A C)  0.201   
total 1 1 1 
Significant at the 0.05 level (2-tailed). For each significant pair, the key of the smaller category is placed under the category with 
the larger proportion 
 
The definition of mixed research forced this type of study typically to have at least 2 F1000 
reviewers, so it has an advantage over the other two types because of the way that FFa scores are 
partly related to the number of reviewers. Those papers recommended by a single reviewer whose 
specialties span both basic and clinical areas, for instance, cardiovascular biology and 
cardiovascular disorders, are also assigned to mixed research. The percentage of articles with FFa 
Score of 1 (53/692, 7.7%) is much smaller for the mixed research level than the basic 
(8,983/18,493, 49%) or clinical (5,385/9,069, 59.4%) research levels. A mixed publication in 
general has at least two recommendations, which implies that mixed publications can be expected 
to have higher FFa scores than basic and clinical publications. Thus a comparison of the mixed 
research with the other two levels for FFa scores is biased. In addition, there is significant 
correlation between FFa scores and citations, a bias in FFa scores implies a bias in citations, i.e., 
publications with multiple recommendations and publications with higher FFa scores generally 
can also be expected to have more citations. To control the potential bias for FFa scores caused by 
the mixed research, only publications assigned to the basic or clinical research levels were 
included for further analysis (Table 6).   
Table 6. Column proportions test (two research levels vs. FFa Scores/Citations) 
Basic Research (A) Clinical research (B) 
FFa Scores above top 0.1% 0.001  0.000  
top 1%-0.1% 0.009 (B) 0.003  
top 10%-1% 0.076 (B) 0.027  
top 20%-10% 0.148 (B) 0.090  
top 50%-20% 0.281  0.286  
below top 50% 0.486  0.594 (A) 
total 1 1 
Citations above top 0.1% 0.001  0.001  
top 1%-0.1% 0.008  0.008  
top 10%-1% 0.096 (B) 0.065  
top 20%-10% 0.112 (B) 0.071  
top 50%-20% 0.327 (B) 0.250  
below top 50% 0.456  0.604 (A) 
total 1 1 
Significant at the 0.05 level (2-tailed). For each significant pair, the key of the smaller category is placed under the category with 
the larger proportion 
 
In Table 5, we defined FFa scores or citations ranked in the top 20% as “excellent” and those 
in the bottom 50% as “common.” More of the “excellent” publications, whether measured by FFa 
scores or citations, were mixed research, with fewer being basic research and clinical research the 
fewest of all. The opposite was true for “common” publications, whether measured by FFa scores 
or citations: most were clinical research, then basic research, then mixed research. Excluding the 
mixed research level (Table 6), the proportion of publications assigned to the basic research level 
exceeds that assigned to the clinical research level for “excellent” articles, whether measured by 
FFa scores or citations. Thus no significant difference was found between FFa scores and citations 
in assessing publication excellence across research levels. We can conclude that research level has 
little impact on the internal consistency of the two measures.  
An article can be assigned to only one research level, but can be tagged with more than one 
label. In the next section, we examine the effect of article type on the difference between FFa 
scores and citations.   
 
Association between citations and FFa scores for different article types 
F1000 reviewers assign labels to each article from a standard list when evaluating and rating 
biomedical articles. As shown in Table 7, the large majority (nearly 75%) of labeled articles were 
marked ‘‘New Finding,’’ while 26% and 23% were categorized as “Interesting Hypothesis” and 
“Confirmation,” respectively. ‘‘Technical Advance,’’ “Controversial’’ and “Novel Drug Target” 
were assigned to 13%, 8% and 5% of articles, respectively. Few articles were labeled ‘‘Changes 
Clinical Practice’’ (1.8%) or “Refutation” (1.3%), with even fewer labeled “Good for Teaching” or 
“General Interest.” 
Within the assigned labels, little internal consistency exists between FFa scores and citations 
(Table 7). For example, the proportion of publications labeled “Clinical Trial: RCT” with top 10% 
citation rankings (3.5%) is significantly larger than for other article types (0.8%‒1.3%), with the 
only exceptions being “Changes Clinical Practice” and “Reputation”. However, a very different 
picture exists for FFa scores ranked in the top 10%. A large difference also exists between the top 
1% of FFa scores and the top 1% of citations for publications with the “Interesting Hypothesis”, 
“Technical Advance” and “Novel Drug Target” labels, the proportions of which exceed those 
labeled “New Finding”, “Confirmation”, “Review/Commentary” and “Non-RCT Clinical Trial” 
when measured by FFa score, yet are similar when measured by citations. The same difference 
exists in publications labeled “General Interest”, “New Finding”, “Confirmation”, “Technical 
Advance”, and so on. Article type seems to substantially impact the difference between FFa scores 
and citations. 
According to the percentile distribution pattern, we divided the sample into four groups:_Group 
1: high FFa scores and high citations (both in top 20%, N=2,506); Group 2: low FFa scores and 
low citations (both in bottom 50%, N=8,971); Group 3: high FFa scores and low citations (in top 
20% and bottom 50%, respectively, N=1,332); and Group 4: low FFa and high citations (bottom 
50% and in top 20%, respectively, N=1,621). 
We then focused on the sub-sample of Groups 3 and 4, which represented inconsistent 
assessment results between FFa scores and citations. Only a few such article types are assigned as 
General Interest and Good for Teaching, which makes no sense for the conclusion. Using column 
proportions tests (Table 7), we found that the non-primary research (such as Review/Commentary) 
or evidence-based research articles (such as Systematic Review/Meta-Analysis, Clinical Trial: 
RCT, Clinical Trial: non-RCT, Confirmation, New Finding and Technical Advance) were more 
likely than other types to be highly cited yet less highly recommended (40%-70% vs. 10%-30%). 
By contrast, the translational or transformative research articles (e.g., Interesting Hypothesis, 
Controversial Topic, Novel Drug Target, Changes Clinical Practice and Refutation) were more 
likely to be highly rated by peer reviewers yet less cited than articles with other labels (60%-80% 
vs. 20%-50%).  
Additionally, we have used a citation window of 3-5 years for articles published in 2010. In 
fact, for all articles included in this study published between 1999 and 2010, it is a citation 
window of 3-15 years. This means that articles from 1999 will have 15 years of citations and 
articles from 2010 will have 3-4 years of citations. Other factors being equal, articles from 1999 
could be expected to have perhaps three or four times more citations than articles from 2010 in our 
dataset, which may bias the conclusions. In order to figure out whether the differences related to 
citations are due to changes of different article types over time, we reported the proportions of the 
28254 articles classified as non-primary research or evidence-based research, and translational 
research or transformative research by year (Figure 4). Figure 4 showed that non-primary research 
or evidence-based research articles seem to be more common than translational research or 
transformative research articles for earlier years (80% versus 20%). Nevertheless, the percentage 
of the former research type showed a “slow decline—subtle rise” trend and the latter just the 
opposite. In general, the proportions of two research types have not witnessed a substantial change 
annually. They appear to be maintained at a relatively stable level, i.e., 75% and 25%, respectively. 
We could conclude that the use of a variable citation window (3-15 years) does not make a great 
difference on the above mentioned results.  
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Figure 4. The proportions of articles in each category by year 
  
 
 
Table 7. Column proportions test (article types v.s. Citations/FFa Scores) 
 
Interesting 
Hypothesis
(A) 
New 
Finding 
(B) 
Confirmation 
(C) 
Technical 
Advance
(D) 
Controversial
(E) 
Novel 
Drug 
Target
(F) 
Clinical 
Trial: RCT
(G) 
Good for 
Teaching 
(H) 
Review/ 
Commentary 
(I) 
Clinical Trial: 
Non-RCT 
(J) 
Changes 
Clinical 
Practice 
(K) 
Systematic 
Review/ 
Meta-analysis
(L) 
Refutation
(M) 
General 
Interest 
(N) 
N (total) 7296 20937 6574 3807 2264 1505 1394 52 830 1068 495 44 354 11 
Citations            
above Top 0.1% 0.001  0.001  0.002  0.003  0.000  0 (.a) 0.004 (B) 0 (.a) 0.002  0.002  0 (.a) 0 (.a) 0.003  0 (.a) 
Top 1%~0.1% 0.012  0.010  0.013  0.017 (B) 0.012  0.009  0.035 (A B C 
D E F I J) 
0.019  0.011  0.008  0.051 (A B C 
D E F I J) 
0 (.a) 0.020  0.091  
Top 10%~1% 0.112 (B) 0.099  0.102  0.125 (B C 
J) 
0.115  0.106  0.166 (A B C 
D E F I J) 
0.096  0.102  0.080  0.17 (A B C F 
I J) 
0.159  0.099  0.091  
Top 20%~10% 0.113  0.111  0.102  0.122 (J) 0.109  0.109  0.131 (C J) 0.115  0.099  0.081  0.087  0.136  0.071  0.091  
Top 50%~20% 0.308  0.32 (C) 0.299  0.301  0.294  0.304  0.280  0.231  0.281  0.318  0.255  0.364  0.302  0.182  
below Top 50% 0.455 (G) 0.459 (G) 0.483 (A B D G) 0.432  0.47 (G) 0.471 (G) 0.383  0.538  0.505 (D G) 0.511 (A B D G)0.438  0.341  0.506 (G) 0.545  
FFa Scores               
above Top 0.1%  0.003 (B) 0.001  0.002  0.004 (B) 0.003  0.005 (B) 0.001  0 (.a) 0 (.a) 0 (.a) 0 (.a) 0 (.a) 0.008 (B) 0.091 (A B 
C D E F G) 
Top 1%~0.1% 0.022 (B C I J) 0.010  0.014  0.022 (B C I 
J) 
0.019 (B I J) 0.026 (B 
C I J) 
0.013  0 (.a) 0.001  0.003  0.03 (B I J) 0 (.a) 0.023 (I J) 0.091 (I J) 
Top 10%~1% 0.132 (B C G I 
J) 
0.085 (I J) 0.086 (I J) 0.137 (B C 
G I J) 
0.13 (B C G I 
J) 
0.139 (B 
C G I J) 
0.077 (I J) 0.096  0.022  0.037  0.166 (B C G 
I J) 
0.114 (I) 0.107 (I J) 0.364 (G I J) 
Top 20%~10% 0.185 (B C I J) 0.158 (C I 
J) 
0.138 (I J) 0.179 (B C I 
J) 
0.189 (B C I 
J) 
0.191 (B 
C I J) 
0.165 (I J) 0.25 (I J) 0.073  0.086  0.21 (C I J) 0.068  0.184 (I J) 0.182  
Top 50%~20% 0.267  0.284 (A 
C) 
0.260  0.261  0.270  0.279  0.307 (C) 0.423  0.339 (A B C D E 
J) 
0.265  0.362 (A B C 
D E F J) 
0.182  0.302  0.273  
below Top 50% 0.391 (K) 0.461 (A D 
E F K) 
0.501 (A B D E F 
G H K M) 
0.397 (K) 0.389 (K) 0.36 (K) 0.436 (F K) 0.231  0.565 (A B C D E 
F G H K M) 
0.61 (A B C D E 
F G H K M) 
0.232  0.636 (F H K) 0.376 (K) 0 (.a) 
Two opposite groups of Citations and FFa Scores 
N (only Group 3 and 
4) 
823 2246 647 451 259 146 177 8 107 108 51 13 41 3 
low FFa Scores but 
high citations 
0.352   0.502 
(A E F M) 
0.556  
(A D E F K M) 
0.448  
(A E F M)
0.301   0.267   0.701  
(A B C D E 
F K M) 
0.25   0.766  
(A B C D E F K 
M) 
0.722  
(A B C D E F K 
M) 
0.314   0.769  
(E F M) 
0.146   0 (.a) 
high FFa Scores 
but low citations 
0.648  
(B C D G I J 
L) 
0.498  
(G I J) 
0.444  
(G I J) 
0.552  
(C G I J) 
0.699  
(B C D G I J 
L) 
0.733  
(B C D G 
I J L) 
0.299   0.75   0.234   0.278   0.686  
(C G I J L) 
0.231   0.854 
(B C G I J 
L) 
1 (.a) 
Significant at the 0.05 level (2-tailed). For each significant pair, the key of the smaller category is placed under the category with the larger proportion. a. The column proportion is 0 or 1, not for compare; b. 
Bonferroni adjustments are used to adjust the significance values. 
 
Discussion and Conclusions  
Few empirical studies have looked at the main reasons for the differences between citation 
analysis and peer review. In this paper, we investigated the effect of research level and article type 
on the consistency of assessments by citations and FFa scores. We found that research level has 
little impact on the internal consistency of these two measures. In general, whether measured by 
citations or FFa scores, significantly more articles assigned to mixed research scored highly than 
those assigned to basic research, which scored higher than clinical research articles. This result, to 
some extent, is in agreement with the finding of van Eck et al., (2013)’s finding that low-impact 
research areas tend to focus on clinical intervention research, while high-impact research areas are 
often more oriented to basic and diagnostic research. It seems that, when compared with the 
absolute number of such measures as citations and FFa scores, both citation analysis and peer 
review may underestimate the impact of clinical research as compared to basic research. When 
taking article types into account, only one study examined the effect of F1000 labels on the 
association between FFa scores and citations (Mohammadi & Thelwall, 2013). That study took a 
random sample of F1000 medical articles and found that citation counts and FFa scores were 
significantly different for only two types of articles, namely “New Finding” and “Changes Clinical 
Practice”. FFa scores value the appropriateness of medical research for clinical practice and “New 
Finding” articles are more highly cited. These conclusions were based on a small-scale sample 
which was limited to medical articles only. In our study, we analyzed a larger-scale and more 
strictly predefined sample of publications from three pairs of research fields representing the 
biological and corresponding medical research within the same disease area. We found that article 
type, as assigned by F1000 faculty members, has a substantial effect on the difference between 
FFa scores and citations. The two measures represent significantly different things for the two 
groups of article types. Articles in the first group are more highly cited rather than highly 
recommended. These mainly include non-primary research, such as review/commentary and 
systematic review/meta-analysis, and evidence based research, such as RCTs, confirmation, new 
finding and technical advances. The use of a variable citation window (3-15 years) does not 
greatly affect this result. Publications in the second group, however, are more highly 
recommended but gather relatively fewer citations. This group mainly involves either translational 
research (such as research indicating novel drug targets or with the potential for changing clinical 
practice) or transformative research (such as interesting hypotheses, controversial topics and 
refutation of currently held beliefs). FFa scores appear to be more conducive than citations to 
identifying important articles for clinical and translational research, transformative research and 
high risk research. This difference can be expected because academic authors are the ones who 
cite previous studies while an article’s potential for scientific revolution or changing clinical 
practice is evaluated from the perspective of practitioners.  
But both citations and FFa scores in research evaluation have innate limitations in research 
evaluation. In a recent editorial, Marks, Marsh, Schroer, and Stevens (2013) noted an alarming 
trend within the biological/biomedical research literature toward the citation of review articles 
rather than the primary research papers in which the original findings were described. Others have 
also pointed out that reviews, or secondary literature, are more cited than the original research 
papers. Patsopoulos, Analatos, and Ioannidis (2005) measured the citation impact of articles using 
various study designs—including meta-analyses, RCTs, cohort studies, case-control studies, case 
reports, nonsystematic reviews and decision analysis or cost-effectiveness analysis—and found 
that the citation impact of various study designs follows the order proposed by most current 
theoretical hierarchies of evidence. Overall, meta-analyses received more citations than any other 
study design both in the first two years after publication and in the longer term, RCTs become the 
second most cited study design and case reports have negligible impact. Knottnerus and 
Knottnerus (2009) also found that systematic reviews currently attract many more citations than 
the original studies. Our study is commensurate with and further validates the above mentioned 
arguments: the secondary literature and the research evidence are more cited. No wonder several 
excellent journals such as Molecular Biology of the Cell, EMBO Journal and Traffic have taken 
action to recognize the contribution of original research more appropriately, e.g., instructing 
authors to cite the primary literature and to limit the citation of review articles, and asking referees 
to note when too many reviews are cited in preference to original publications. The San Francisco 
DORA also recommended that researchers “wherever appropriate, cite primary literature in which 
observations are first reported rather than reviews in order to give credit where credit is due.” In 
addition, since citation is one type of measure which increases with time, and different research 
fields have different citation speeds and citation durability; in addition, individual papers vary in 
their aging patterns (Costas, Van Leeuwen, & Van Raan, 2010; Van Raan, 2004; Wang, 2013). 
These elements must be taken into account when using citation analysis for research evaluations 
and funding allocations, and thus micro-level analysis (and especially analysis of the individual 
level) is one of the most difficult and problematic levels of analysis in bibliometric studies. 
FFa scores in the F1000 system also have obvious limitations. First, while making citations is 
relatively easy, recommendations are more time-consuming and therefore less numerous, leading 
to many ties and thus reducing their usefulness for ranking articles. Second, the large numbers of 
citations clearly produces a reliable source of data; however, the number of recommendations is 
much smaller, making it a less reliable data source than citations. The limited availability of 
recommendations has to do with their reliability. Additionally, the academic position of F1000 
experts is unknown despite the importance of the academic status of reviewers, and the points 
scheme used by F1000 to convert judgments into a score is relatively arbitrary, such that the 
article ranking varies according to the details of the scheme. Finally, subjective assessments of the 
merit and likely impact of scientific publications often manifest biases in the form of low 
inter-rater reliability. Using two large datasets, including F1000 and a Wellcome Trust grant panel, 
in which scientists make qualitative assessments of scientific merit, Eyre-Walker and Stoletzki 
(2013) showed that scientists’ judgments are strongly influenced by the journal in which a paper is 
published and cannot consistently and independently judge the merit of a paper, or predict its 
future impact as measured by citations. Bornmann (2014) also argued that analyses of the 
reliability of the F1000Prime peer review system showed low agreement among faculty members. 
Despite its problems, the subjective assessment of research by experts has always been considered 
a gold standard, and has been championed by researchers and funders alike. Yet the analysis 
mentioned above now raises serious questions about this process (Eisen, MacCallum, & Neylon, 
2013).  
Although imperfect, citation and recommendation are still important tools for scientific 
recognition. The data and indicators provided by F1000 are undoubtedly rich and valuable, and 
this tool has strong potential for research evaluation, being a good complement to alternative 
metrics for research assessments. Furthermore, since most studied articles were reviewed in the 
year of publication (Waltman & Costas, 2014), F1000 can be useful when quick evaluations are 
needed. However, compared with citations, F1000 fails to consistently and dynamically identify 
the most important publications in a long time window. 
One limitation of this study is that we used the specialty information of faculty members in 
F1000 to assign articles to the basic, clinical or mixed research levels. F1000 reviewers and the 
number of reviewed papers were not distributed uniformly across the disciplines. A paper can be 
reviewed by faculty members specialized in several subjects, including those with specialties not 
covered by the six subjects included in this study, which may cause biases in the classification of 
publications according to research levels. Currently no consensus exists regarding the 
methodology used to classify publications into research levels along the basic-to-applied spectrum 
of research (Boyack, Patek, Ungar, Yoon, & Klavans, 2014), especially with the increase in 
university-government-industry partnerships in biomedical sciences (Campbell, Powers, 
Blumenthal, & Biles, 2004). Nevertheless, we are confident that, as a quantitative study on the 
effect of research level and article type on the differences between citation analysis and peer 
reviews, our study has achieved its purpose: to answer questions about the degree of correlation of 
recommendations with citations, and whether recommendations capture something different from 
citations.  
Attempts to improve the application of bibliometric tools in research assessment procedures 
should consider the proportions of three types of publications: (1) evidence based research 
publications; (2) transformative research or high risk research publications; and (3) translational 
research publications. Further analysis that considers these three types of publications might 
reveal new and useful information, which may help more accurately determine the relative value 
of different scholarly contributions. 
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